FOLH1 and neoplasm: However, the PSMA PET prognostic penetrance is challenged by the acknowledged limitation of PET imaging that underestimates tracer concentration in small tumours and by the notion that 5–10% of clinically relevant PCa do not express this protein [14, 15].